Moneycontrol PRO
you are here: HomeNewsTrendsHealth

Biocon Biologics' new manufacturing plant in Bengaluru gets EU certification

The manufacturing facility will enhance the company's capability to manufacture drug substance of monoclonal antibodies portfolio.

July 05, 2022 / 07:40 PM IST
Biocon Biologics Limited is a subsidiary of Biocon Limited.

Biocon Biologics Limited is a subsidiary of Biocon Limited.

Biocon Biologics Limited, a subsidiary of Biocon Limited, has received the European Union's good manufacturing practice (GMP) certificate from the Health Products Regulatory Authority (HPRA) Ireland for its new monoclonal antibodies (mAbs) drug substance manufacturing facility in Bengaluru.

The certification came after a GMP inspection of the plant in April 2022.

According to the company, the facility that spreads across 340,000 square feet will enhance the company's capability to manufacture the drug substance of mAbs portfolio and will enable it to serve patients across the globe.

"This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing. Upon successful completion and qualification in 2021, it was awarded the Facility of the Year Award with an Honorable Mention by the International Society for Pharmaceutical Engineering,” said a company spokesperson.
Moneycontrol News
first published: Jul 5, 2022 07:27 pm
Sections
ISO 27001 - BSI Assurance Mark